Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece

Table 3

Association of basic patient and tumor characteristics with first-line chemotherapy regimen.

Characteristics			Chemotherapy regimen
			Nab-paclitaxel-gemcitabine	FOLFIRINOX/CAPOXIRI	Gemcitabine	Others	value
Age (years)	<70	N (%)	70	36	7	18	0.003
			61.9	85.7	43.8	81.8
	≥70	N (%)	43	6	9	4
			38.1	14.3	56.2	18.2
Sex	Male	N (%)	59	26	6	14	0.287
			52.2	61.9	37.5	63.6
	Female	N (%)	54	16	10	8
			47.8	38.1	62.5	36.4
ECOG PS	0	N (%)	49	22	1	12	<0.001
			55.0	62.9	8.3	70.6
	1	N (%)	37	12	5	4
			41.6	34.2	41.7	23.5
	2-3	N (%)	3	1	6	1
			3.4	2.9	50.0	5.9
Tumor stage	III	N (%)	15	4	4	1	0.010
			13.5	10.0	25.0	4.5
	IV	N (%)	74	19	12	13
			66.7	47.5	75.0	59.1
	Relapse	N (%)	22	17	0	8
			19.8	42.5	0.0	36.4
Total	N (%)	111	40	16	22
		100.0%	100.0	100.0	100.0